SCHEMBL6137288

SCHEMBL6137288

CCCC[C@@H](O)C=CCCCCCCCCCCCCCC(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
CYP3A4 P08684 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
DGKA P23743 1/20 0.55
PPARG P37231 2/20 0.51
GPR132 Q9UNW8 1/20 0.51
FAAH O00519 2/20 0.50
LPAR1 Q92633 6/20 0.49
ENPP2 Q13822 2/20 0.49
LPAR4 Q99677 2/20 0.49
LPAR5 Q9H1C0 2/20 0.49
LPAR2 Q9HBW0 2/20 0.49
LPAR3 Q9UBY5 2/20 0.49
CES2 O00748 1/20 0.49
LPAR6 P43657 1/20 0.49
TRPV1 Q8NER1 1/20 0.49
PRKCE Q02156 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137304 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137294 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137284 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137416 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6386545 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137276 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137407 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6386552 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137412 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL6137301 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4ALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050038259-A1 Hydroxyeicosenoic acid anaglogs TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-02-17 US disclosed
EP-1425258-A4 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO LTD (JP) 2005-02-16 EP disclosed
EP-1425258-A2 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO., LTD (JP) 2004-06-09 EP disclosed
WO-2003024390-A2 HYDROXYEICOSENOIC ACID ANALOGS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038259-A1 Hydroxyeicosenoic acid anaglogs HCAR1, HRH4, HCAR3 ALDH1A1 1290/4885CYP3A4 328/4885ALOX15 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.